Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential.

Leukemia·2021
Same author

Correction: Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential.

Leukemia·2021
Same author

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO).

Annals of hematology·2017
Same author

Topological cell clustering in the ATLAS calorimeters and its performance in LHC Run 1.

The European physical journal. C, Particles and fields·2017
Same author

Measurements of top-quark pair differential cross-sections in the lepton+jets channel in <i>pp</i> collisions at [Formula: see text] using the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Performance of pile-up mitigation techniques for jets in [Formula: see text] collisions at [Formula: see text] TeV using the ATLAS detector.

The European physical journal. C, Particles and fields·2017

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms
08:32

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Published on: March 22, 2024

1.8K

Tendon healing induced by chemically modified mRNAs.

K Groth, T Berezhanskyy, M K Aneja

  • 1Ethris GmbH, Semmelweisstr. 3, 82152 Planegg, Germany.rudolph@ethris.com.

European Cells & Materials
|May 25, 2017
PubMed
Summary
This summary is machine-generated.

Chemically-modified mRNA (cmRNA) effectively promotes therapeutic protein expression in tendons, offering a novel treatment for tendon disorders and improving healing. This innovative approach shows promise for reducing re-injury rates and enhancing recovery.

More Related Videos

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells
14:04

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Published on: August 1, 2020

6.4K
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
04:48

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Published on: March 1, 2024

2.4K

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms
08:32

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Published on: March 22, 2024

1.8K
Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells
14:04

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Published on: August 1, 2020

6.4K
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
04:48

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Published on: March 1, 2024

2.4K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Orthopedics

Background:

  • Tendon disorders are prevalent in human and veterinary medicine, characterized by high re-injury rates and limited therapeutic options.
  • Current treatments for tendon healing are often unsatisfactory, necessitating innovative therapeutic strategies.

Purpose of the Study:

  • To evaluate the potential of naked, chemically-modified mRNA (cmRNA) encoding therapeutic proteins for enhancing tendon healing.
  • To assess protein expression and therapeutic effects of cmRNA in healthy and injured tendons.

Main Methods:

  • Injection of naked cmRNA encoding bone morphogenetic protein 7 (BMP-7) into healthy and experimentally-injured tendons in a large animal model.
  • Quantification of BMP-7 protein expression and analysis of collagen type III formation.
  • Assessment of reporter protein expression in inflamed tendons.

Main Results:

  • Naked cmRNA injection resulted in high therapeutic protein expression in both healthy and injured tendons.
  • BMP-7 encoding cmRNA significantly increased BMP-7 protein levels and reduced collagen type III formation compared to controls.
  • Reporter protein expression was observed in healthy, injured, and severely inflamed tendons.

Conclusions:

  • Chemically-modified mRNA (cmRNA) demonstrates significant potential as a novel drug class for treating tendon disorders.
  • This approach facilitates high therapeutic protein expression in tendons, supporting improved healing and reduced inflammation.
  • cmRNA technology offers a promising new avenue for addressing the unmet needs in tendon repair and regeneration.